Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome.
Jensen
P D
PD
University Department of Medicine and Haematology, Aarhus Amtssygehus, Denmark.
Jensen
I M
IM
Ellegaard
J
J
D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D003676:Deferoxamine / Q000627:therapeutic use*; D004909:Erythrocyte Indices; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*; D010976:Platelet Count; D012189:Retrospective Studies; D013997:Time Factors
D003676:Deferoxamine